Skip to content

Author

Fahad S. Alshehri

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Pharmacists’ Perspectives on Functional Medication-Use Challenges and Potential Adaptations for People with Disabilities in Saudi Arabia: A Qualitative Study

Background: People with disabilities may face medication-safety challenges when functional limitations interfere with medication handling, administration, communication, self-management, or continuity of treatment. This study examined pharmacists’ experiences and perceptions of safe medication use among people with dis...

F. Alshehri, N. Alorfi, Nouf M. Alourfi et al. · 0 citations
Open access Aug 2026

Pregabalin-associated adverse drug reactions

Pregabalin is widely used for neuropathic pain, epilepsy, and anxiety disorders but has become increasingly associated with misuse and dependence. Understanding its global safety profile is essential to support pharmacovigilance and toxicovigilance efforts. This study aimed to characterize the pharmacological and toxic...

F. Alshehri, Ahmed M. Ashour, Nasser M. Alorfi et al. · 0 citations
Open access Aug 2026

pH-Responsive Carboxymethyl Cellulose-Encapsulating Hesperidin–Selenium Nanoparticles Attenuate Paracetamol-Induced Acute Kidney Injury via Keap-1/Nrf2, NF-κB, and Mitochondrial Apoptosis Modulation

Paracetamol overdose is a major cause of drug-induced acute kidney injury (AKI), driven by oxidative stress, inflammation, mitochondrial dysfunction, and tubular apoptosis. This study evaluated the nephroprotective efficacy of pH-responsive carboxymethyl cellulose-encapsulated hesperidin-stabilized selenium nanoparticl...

Mohamed H. A. Gadelmawla, Khaled M. Alam-Eldein, A. Saleh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.